TIDMDPH

RNS Number : 6577R

Dechra Pharmaceuticals PLC

09 March 2021

9 March 2021

Dechra Pharmaceuticals PLC

(the Company)

Notification of Transactions by Persons Discharging Managerial Responsibilities

Dechra Pharmaceuticals PLC has been notified that on 9 March 2021 Alison Platt, Non-Executive Director, purchased 603 ordinary shares in the Company.

Following this acquisition, Alison Platt's beneficial interest in the Company is 1,363 shares (0.001% of the current issued share capital).

The Notification of Dealing Form set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

Notification of Dealing Form

 
 1.    Details of the Person Discharging Managerial Responsibility 
        ("PDMR")/person closely associated with them ("PCA") 
 a)    Name                                   Alison Platt 
      -------------------------------------  ----------------------------------- 
 2.    Reason for the notification 
      -------------------------------------------------------------------------- 
 a)    Position/status                        Director 
      -------------------------------------  ----------------------------------- 
 b)    Initial notification/                  Initial Notification 
        amendment 
      -------------------------------------  ----------------------------------- 
 3.    Details of the Issuer 
      -------------------------------------------------------------------------- 
 a)    Name                                   Dechra Pharmaceuticals PLC 
      -------------------------------------  ----------------------------------- 
 b)    LEI code                               213800J4UVB5OWG8VX82 
      -------------------------------------  ----------------------------------- 
 4.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of 
        transaction; (iii) each date; and (iv) each place 
        where transactions have been conducted 
      -------------------------------------------------------------------------- 
 a)    Description of                         Ordinary Shares of 1 pence each 
        the financial 
        instrument 
                                               ISIN: GB0009633180 
        Identification 
        code 
      -------------------------------------  ----------------------------------- 
 b)    Nature of the                          Purchase of Shares 
        transaction 
      -------------------------------------  ----------------------------------- 
                                              Price(s) 
 c)    Price(s) and volumes(s)                 GBP32.905000               603 
      -------------------------------------  ------------------------  --------- 
 d)         Aggregated information 
              *    Aggregate volume             603 
 
                                                GBP32.905000 
              *    Price                        GBP19,841.72 
 
 
              *    Total 
      -------------------------------------  ----------------------------------- 
 e)    Date of the transaction                2021-03-09 
      -------------------------------------  ----------------------------------- 
 f)    Place of the transaction               London Stock Exchange 
      -------------------------------------  -----------------------------------

For further information, please contact:

Melanie Hall, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDKCBQDBKDPNK

(END) Dow Jones Newswires

March 09, 2021 06:46 ET (11:46 GMT)

Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Dechra Pharmaceuticals Charts.
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Dechra Pharmaceuticals Charts.